MODERN CHI MED discloses further details on high shareholding concentration; majority stake held by key insiders

Bulletin Express04-17

Modern Chinese Medicine Group Co., Ltd. (MODERN CHI MED) issued a supplemental announcement on 17 April 2026, expanding on the Securities and Futures Commission’s (SFC) earlier warning about high concentration of share ownership in the company’s shares.

According to the updated disclosure, four identifiable parties collectively control 537.05 million shares, representing 74.5% of the company’s issued share capital:

• Modern Biotechnology Group Holdings Co., Ltd. holds 402.00 million shares, or 55.8% of the total. Modern Biotechnology is wholly owned by Chairlady and Executive Director Ms. Sun Xinlei, making her the single largest beneficial owner under the Securities and Futures Ordinance (SFO).

• Universal Health (Global) Investment Fund Management Ltd. owns 120.50 million shares, equal to 16.7% of the issued shares. Universal Health is wholly owned by Ms. Chen Xiaoyan, who is deemed interested in the entire stake under the SFO.

• Mr. Jin Dongtao, spouse of Ms. Chen, directly holds 10.86 million shares (1.5%).

• Mr. Jin Tian Jixiang, son of Mr. Jin Dongtao, controls 3.70 million shares (0.5%).

The board stated it has no knowledge of the identities or individual stakes of the remaining unnamed shareholders highlighted in the SFC’s notice. Investors are reminded that a narrowly held share base can affect market liquidity and trading dynamics.

The board currently comprises three executive directors—Ms. Sun Xinlei, Ms. Zhang Hongli and Ms. Jia Yanru—and three independent non-executive directors—Ms. Liu Ling, Mr. Leung Tsz Wing and Mr. Wong Chi Kin.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1162661420?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-17 23:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1162661420","market":"us","top_or_hot":-1,"title":"MODERN CHI MED discloses further details on high shareholding concentration; majority stake held by key insiders","media":"Bulletin Express","content":"<p>Modern Chinese Medicine Group Co., Ltd. (MODERN CHI MED) issued a supplemental announcement on 17 April 2026, expanding on the Securities and Futures Commission’s (SFC) earlier warning about high concentration of share ownership in the company’s shares.</p>\n<p>According to the updated disclosure, four identifiable parties collectively control 537.05 million shares, representing 74.5% of the company’s issued share capital:</p>\n<p>• Modern Biotechnology Group Holdings Co., Ltd. holds 402.00 million shares, or 55.8% of the total. Modern Biotechnology is wholly owned by Chairlady and Executive Director Ms. Sun Xinlei, making her the single largest beneficial owner under the Securities and Futures Ordinance (SFO).</p>\n<p>• Universal Health (Global) Investment Fund Management Ltd. owns 120.50 million shares, equal to 16.7% of the issued shares. Universal Health is wholly owned by Ms. Chen Xiaoyan, who is deemed interested in the entire stake under the SFO.</p>\n<p>• Mr. Jin Dongtao, spouse of Ms. Chen, directly holds 10.86 million shares (1.5%).</p>\n<p>• Mr. Jin Tian Jixiang, son of Mr. Jin Dongtao, controls 3.70 million shares (0.5%).</p>\n<p>The board stated it has no knowledge of the identities or individual stakes of the remaining unnamed shareholders highlighted in the SFC’s notice. Investors are reminded that a narrowly held share base can affect market liquidity and trading dynamics.</p>\n<p>The board currently comprises three executive directors—Ms. Sun Xinlei, Ms. Zhang Hongli and Ms. Jia Yanru—and three independent non-executive directors—Ms. Liu Ling, Mr. Leung Tsz Wing and Mr. Wong Chi Kin.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MODERN CHI MED discloses further details on high shareholding concentration; majority stake held by key insiders</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMODERN CHI MED discloses further details on high shareholding concentration; majority stake held by key insiders\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-17 23:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Modern Chinese Medicine Group Co., Ltd. (MODERN CHI MED) issued a supplemental announcement on 17 April 2026, expanding on the Securities and Futures Commission’s (SFC) earlier warning about high concentration of share ownership in the company’s shares.</p>\n<p>According to the updated disclosure, four identifiable parties collectively control 537.05 million shares, representing 74.5% of the company’s issued share capital:</p>\n<p>• Modern Biotechnology Group Holdings Co., Ltd. holds 402.00 million shares, or 55.8% of the total. Modern Biotechnology is wholly owned by Chairlady and Executive Director Ms. Sun Xinlei, making her the single largest beneficial owner under the Securities and Futures Ordinance (SFO).</p>\n<p>• Universal Health (Global) Investment Fund Management Ltd. owns 120.50 million shares, equal to 16.7% of the issued shares. Universal Health is wholly owned by Ms. Chen Xiaoyan, who is deemed interested in the entire stake under the SFO.</p>\n<p>• Mr. Jin Dongtao, spouse of Ms. Chen, directly holds 10.86 million shares (1.5%).</p>\n<p>• Mr. Jin Tian Jixiang, son of Mr. Jin Dongtao, controls 3.70 million shares (0.5%).</p>\n<p>The board stated it has no knowledge of the identities or individual stakes of the remaining unnamed shareholders highlighted in the SFC’s notice. Investors are reminded that a narrowly held share base can affect market liquidity and trading dynamics.</p>\n<p>The board currently comprises three executive directors—Ms. Sun Xinlei, Ms. Zhang Hongli and Ms. Jia Yanru—and three independent non-executive directors—Ms. Liu Ling, Mr. Leung Tsz Wing and Mr. Wong Chi Kin.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01643","symbol_name":"现代中药集团","start_time":0,"source_url":"","article_id":"1162661420","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1162661420","pubTimestamp":1776438202,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Modern Chinese Medicine Group Co., Ltd. (MODERN CHI MED) issued a supplemental announcement on 17 April 2026, expanding on the Securities and Futures Commission’s (SFC) earlier warning about high...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01643":"现代中药集团"},"translate_title":"现代和黄医药披露股权高度集中的进一步细节；主要内部人士持有的多数股权","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01643":1},"content_text":"Modern Chinese Medicine Group Co., Ltd. (MODERN CHI MED) issued a supplemental announcement on 17 April 2026, expanding on the Securities and Futures Commission’s (SFC) earlier warning about high concentration of share ownership in the company’s shares.\nAccording to the updated disclosure, four identifiable parties collectively control 537.05 million shares, representing 74.5% of the company’s issued share capital:\n• Modern Biotechnology Group Holdings Co., Ltd. holds 402.00 million shares, or 55.8% of the total. Modern Biotechnology is wholly owned by Chairlady and Executive Director Ms. Sun Xinlei, making her the single largest beneficial owner under the Securities and Futures Ordinance (SFO).\n• Universal Health (Global) Investment Fund Management Ltd. owns 120.50 million shares, equal to 16.7% of the issued shares. Universal Health is wholly owned by Ms. Chen Xiaoyan, who is deemed interested in the entire stake under the SFO.\n• Mr. Jin Dongtao, spouse of Ms. Chen, directly holds 10.86 million shares (1.5%).\n• Mr. Jin Tian Jixiang, son of Mr. Jin Dongtao, controls 3.70 million shares (0.5%).\nThe board stated it has no knowledge of the identities or individual stakes of the remaining unnamed shareholders highlighted in the SFC’s notice. Investors are reminded that a narrowly held share base can affect market liquidity and trading dynamics.\nThe board currently comprises three executive directors—Ms. Sun Xinlei, Ms. Zhang Hongli and Ms. Jia Yanru—and three independent non-executive directors—Ms. Liu Ling, Mr. Leung Tsz Wing and Mr. Wong Chi Kin.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1162661420","isCrawlerRequest":true}